ID   MATN2_HUMAN             Reviewed;         956 AA.
AC   O00339; A8K106; E7EW74; E9PD48; E9PGL2; Q6UWA5; Q7Z5X1; Q8NDE6; Q96FT5;
AC   Q9NSZ1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 4.
DT   28-JUN-2023, entry version 209.
DE   RecName: Full=Matrilin-2;
DE   Flags: Precursor;
GN   Name=MATN2; ORFNames=UNQ193/PRO219;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=11124542; DOI=10.1159/000056797;
RA   Muratoglu S., Krysan K., Balazs M., Sheng H., Zakany R., Modis L., Kiss I.,
RA   Deak F.;
RT   "Primary structure of human matrilin-2, chromosome location of the MATN2
RT   gene and conservation of an AT-AC intron in matrilin genes.";
RL   Cytogenet. Cell Genet. 90:323-327(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT MET-187.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND VARIANT GLU-356.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 242-956 (ISOFORM 1), AND VARIANT GLU-356.
RC   TISSUE=Brain, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 644-956.
RX   PubMed=9083061; DOI=10.1074/jbc.272.14.9268;
RA   Deak F., Piecha D., Bachrati C., Paulsson M., Kiss I.;
RT   "Primary structure and expression of matrilin-2, the closest relative of
RT   cartilage matrix protein within the von Willebrand factor type A-like
RT   module superfamily.";
RL   J. Biol. Chem. 272:9268-9274(1997).
CC   -!- FUNCTION: Involved in matrix assembly. {ECO:0000250}.
CC   -!- INTERACTION:
CC       O00339; O15265: ATXN7; NbExp=2; IntAct=EBI-949020, EBI-708350;
CC       O00339; O00555: CACNA1A; NbExp=2; IntAct=EBI-949020, EBI-766279;
CC       O00339; O68704: yopK; Xeno; NbExp=2; IntAct=EBI-949020, EBI-20592411;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long;
CC         IsoId=O00339-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=O00339-2; Sequence=VSP_001399;
CC       Name=3;
CC         IsoId=O00339-3; Sequence=VSP_013284;
CC       Name=4;
CC         IsoId=O00339-4; Sequence=VSP_014540;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD38787.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U69263; AAC51260.2; -; mRNA.
DR   EMBL; AY358895; AAQ89254.1; -; mRNA.
DR   EMBL; AL137638; CAB70853.2; -; mRNA.
DR   EMBL; AK289721; BAF82410.1; -; mRNA.
DR   EMBL; AL833931; CAD38787.1; ALT_INIT; mRNA.
DR   EMBL; AP002906; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003352; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC010444; AAH10444.1; -; mRNA.
DR   EMBL; BC016394; AAH16394.1; -; mRNA.
DR   CCDS; CCDS55264.1; -. [O00339-1]
DR   CCDS; CCDS55265.1; -. [O00339-2]
DR   CCDS; CCDS83309.1; -. [O00339-3]
DR   RefSeq; NP_001304677.1; NM_001317748.1. [O00339-3]
DR   RefSeq; NP_002371.3; NM_002380.4. [O00339-1]
DR   RefSeq; NP_085072.2; NM_030583.3. [O00339-2]
DR   AlphaFoldDB; O00339; -.
DR   BioGRID; 110317; 105.
DR   ComplexPortal; CPX-4464; Matrilin-2 complex.
DR   DIP; DIP-47267N; -.
DR   IntAct; O00339; 9.
DR   MINT; O00339; -.
DR   STRING; 9606.ENSP00000254898; -.
DR   GlyCosmos; O00339; 4 sites, 1 glycan.
DR   GlyGen; O00339; 8 sites, 3 O-linked glycans (7 sites).
DR   iPTMnet; O00339; -.
DR   PhosphoSitePlus; O00339; -.
DR   BioMuta; MATN2; -.
DR   jPOST; O00339; -.
DR   MassIVE; O00339; -.
DR   MaxQB; O00339; -.
DR   PaxDb; O00339; -.
DR   PeptideAtlas; O00339; -.
DR   ProteomicsDB; 47856; -. [O00339-1]
DR   ProteomicsDB; 47857; -. [O00339-2]
DR   ProteomicsDB; 47858; -. [O00339-3]
DR   ProteomicsDB; 47859; -. [O00339-4]
DR   Antibodypedia; 26033; 202 antibodies from 33 providers.
DR   DNASU; 4147; -.
DR   Ensembl; ENST00000254898.7; ENSP00000254898.6; ENSG00000132561.14. [O00339-1]
DR   Ensembl; ENST00000520016.5; ENSP00000430487.1; ENSG00000132561.14. [O00339-1]
DR   Ensembl; ENST00000521689.5; ENSP00000429977.1; ENSG00000132561.14. [O00339-2]
DR   Ensembl; ENST00000522025.6; ENSP00000429010.1; ENSG00000132561.14. [O00339-4]
DR   Ensembl; ENST00000524308.5; ENSP00000430221.1; ENSG00000132561.14. [O00339-3]
DR   GeneID; 4147; -.
DR   KEGG; hsa:4147; -.
DR   MANE-Select; ENST00000254898.7; ENSP00000254898.6; NM_002380.5; NP_002371.3.
DR   UCSC; uc003yic.4; human. [O00339-1]
DR   AGR; HGNC:6908; -.
DR   CTD; 4147; -.
DR   DisGeNET; 4147; -.
DR   GeneCards; MATN2; -.
DR   HGNC; HGNC:6908; MATN2.
DR   HPA; ENSG00000132561; Low tissue specificity.
DR   MIM; 602108; gene.
DR   neXtProt; NX_O00339; -.
DR   OpenTargets; ENSG00000132561; -.
DR   PharmGKB; PA30651; -.
DR   VEuPathDB; HostDB:ENSG00000132561; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   GeneTree; ENSGT00940000158008; -.
DR   HOGENOM; CLU_008905_0_0_1; -.
DR   InParanoid; O00339; -.
DR   OMA; CATEDHA; -.
DR   OrthoDB; 1453590at2759; -.
DR   TreeFam; TF330078; -.
DR   PathwayCommons; O00339; -.
DR   SignaLink; O00339; -.
DR   BioGRID-ORCS; 4147; 10 hits in 1149 CRISPR screens.
DR   ChiTaRS; MATN2; human.
DR   GeneWiki; MATN2; -.
DR   GenomeRNAi; 4147; -.
DR   Pharos; O00339; Tbio.
DR   PRO; PR:O00339; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; O00339; protein.
DR   Bgee; ENSG00000132561; Expressed in tibia and 201 other tissues.
DR   ExpressionAtlas; O00339; baseline and differential.
DR   Genevisible; O00339; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0031012; C:extracellular matrix; NAS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0120216; C:matrilin complex; ISO:ComplexPortal.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; ISS:BHF-UCL.
DR   GO; GO:0030198; P:extracellular matrix organization; NAS:ComplexPortal.
DR   CDD; cd00054; EGF_CA; 2.
DR   CDD; cd01475; vWA_Matrilin; 2.
DR   Gene3D; 1.20.5.30; -; 1.
DR   Gene3D; 2.10.25.10; Laminin; 10.
DR   Gene3D; 3.40.50.410; von Willebrand factor, type A domain; 2.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR036337; Matrilin_cc_sf.
DR   InterPro; IPR019466; Matrilin_coiled-coil_trimer.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR24020; COLLAGEN ALPHA; 1.
DR   PANTHER; PTHR24020:SF35; MATRILIN-2; 1.
DR   Pfam; PF12662; cEGF; 1.
DR   Pfam; PF07645; EGF_CA; 2.
DR   Pfam; PF14670; FXa_inhibition; 4.
DR   Pfam; PF10393; Matrilin_ccoil; 1.
DR   Pfam; PF00092; VWA; 2.
DR   PRINTS; PR00453; VWFADOMAIN.
DR   SMART; SM00181; EGF; 10.
DR   SMART; SM00179; EGF_CA; 10.
DR   SMART; SM01279; Matrilin_ccoil; 1.
DR   SMART; SM00327; VWA; 2.
DR   SUPFAM; SSF58002; Chicken cartilage matrix protein; 1.
DR   SUPFAM; SSF57196; EGF/Laminin; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 3.
DR   SUPFAM; SSF53300; vWA-like; 2.
DR   PROSITE; PS00010; ASX_HYDROXYL; 9.
DR   PROSITE; PS01186; EGF_2; 9.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS50234; VWFA; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..956
FT                   /note="Matrilin-2"
FT                   /id="PRO_0000007655"
FT   DOMAIN          57..232
FT                   /note="VWFA 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00219"
FT   DOMAIN          238..278
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          279..319
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          320..360
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          361..401
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          402..442
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          443..483
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          484..524
FT                   /note="EGF-like 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          525..565
FT                   /note="EGF-like 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          566..606
FT                   /note="EGF-like 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          607..647
FT                   /note="EGF-like 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          655..830
FT                   /note="VWFA 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00219"
FT   REGION          840..863
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          917..955
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        221
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        242..253
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        249..262
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        264..277
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        283..294
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        290..303
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        305..318
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        324..335
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        331..344
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        346..359
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        365..376
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        372..385
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        387..400
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        406..417
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        413..426
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        428..441
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        447..458
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        454..467
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        469..482
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        488..499
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        495..508
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        510..523
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        529..540
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        536..549
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        551..564
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        570..581
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        577..590
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        592..605
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        611..622
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        618..631
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        633..646
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   VAR_SEQ         1..284
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_014540"
FT   VAR_SEQ         361..401
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_013284"
FT   VAR_SEQ         861..879
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11124542,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_001399"
FT   VARIANT         14
FT                   /note="G -> A (in dbSNP:rs35804177)"
FT                   /id="VAR_055753"
FT   VARIANT         187
FT                   /note="T -> M (in dbSNP:rs2290472)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_055754"
FT   VARIANT         356
FT                   /note="K -> E (in dbSNP:rs1869609)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17974005"
FT                   /id="VAR_021568"
FT   VARIANT         599
FT                   /note="A -> T (in dbSNP:rs35120814)"
FT                   /id="VAR_055755"
FT   VARIANT         855
FT                   /note="T -> M (in dbSNP:rs2255317)"
FT                   /id="VAR_055756"
FT   VARIANT         932
FT                   /note="V -> I (in dbSNP:rs17831160)"
FT                   /id="VAR_055757"
FT   CONFLICT        58
FT                   /note="L -> P (in Ref. 3; BAF82410)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        594
FT                   /note="E -> V (in Ref. 1; AAC51260)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        644
FT                   /note="R -> G (in Ref. 7; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        755
FT                   /note="L -> F (in Ref. 1; AAC51260)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        890
FT                   /note="N -> D (in Ref. 3; BAF82410)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        935
FT                   /note="L -> F (in Ref. 7; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   956 AA;  106837 MW;  D0868FBF62744EF2 CRC64;
     MEKMLAGCFL LILGQIVLLP AEARERSRGR SISRGRHART HPQTALLESS CENKRADLVF
     IIDSSRSVNT HDYAKVKEFI VDILQFLDIG PDVTRVGLLQ YGSTVKNEFS LKTFKRKSEV
     ERAVKRMRHL STGTMTGLAI QYALNIAFSE AEGARPLREN VPRVIMIVTD GRPQDSVAEV
     AAKARDTGIL IFAIGVGQVD FNTLKSIGSE PHEDHVFLVA NFSQIETLTS VFQKKLCTAH
     MCSTLEHNCA HFCINIPGSY VCRCKQGYIL NSDQTTCRIQ DLCAMEDHNC EQLCVNVPGS
     FVCQCYSGYA LAEDGKRCVA VDYCASENHG CEHECVNADG SYLCQCHEGF ALNPDKKTCT
     KIDYCASSNH GCQHECVNTD DSYSCHCLKG FTLNPDKKTC RRINYCALNK PGCEHECVNM
     EESYYCRCHR GYTLDPNGKT CSRVDHCAQQ DHGCEQLCLN TEDSFVCQCS EGFLINEDLK
     TCSRVDYCLL SDHGCEYSCV NMDRSFACQC PEGHVLRSDG KTCAKLDSCA LGDHGCEHSC
     VSSEDSFVCQ CFEGYILRED GKTCRRKDVC QAIDHGCEHI CVNSDDSYTC ECLEGFRLAE
     DGKRCRRKDV CKSTHHGCEH ICVNNGNSYI CKCSEGFVLA EDGRRCKKCT EGPIDLVFVI
     DGSKSLGEEN FEVVKQFVTG IIDSLTISPK AARVGLLQYS TQVHTEFTLR NFNSAKDMKK
     AVAHMKYMGK GSMTGLALKH MFERSFTQGE GARPLSTRVP RAAIVFTDGR AQDDVSEWAS
     KAKANGITMY AVGVGKAIEE ELQEIASEPT NKHLFYAEDF STMDEISEKL KKGICEALED
     SDGRQDSPAG ELPKTVQQPT ESEPVTINIQ DLLSCSNFAV QHRYLFEEDN LLRSTQKLSH
     STKPSGSPLE EKHDQCKCEN LIMFQNLANE EVRKLTQRLE EMTQRMEALE NRLRYR
//
